Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional study (Q38127164)

From Wikidata
Jump to navigation Jump to search
scientific article published on 06 August 2013
edit
Language Label Description Also known as
English
Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional study
scientific article published on 06 August 2013

    Statements

    Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional study (English)
    0 references
    0 references
    0 references
    Vincent Castonguay
    Michael L Friedlander

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit